Nova TheraNostics, Inc.

A next generation MRI contrast agent that is safer, providing better images at lower doses and can be used in people with kidney disease where others cannot.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2013
  • Employees 3
  • Website novatheranostics.com

Company Summary

Nova TheraNostics (NTN) is developing a new and uniquely differentiated contrast agent for use with magnetic resonance imaging (MRI) that will not only be highly competitive relative to existing agents, but will also enable the extension of contrast MRI into new indications not currently served by this imaging modality.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free